VACULOVÁ, Jitka, Jiří DOLINA, Petr JABANDŽIEV, Martin ŠTĚRBA, Jiří TŮMA, Robert DOUŠEK, Ladislav PLÁNKA, Jan ŠENKYŘÍK, Jaroslav ŠTĚRBA, Viera BAJČIOVÁ, Michal EID, Zdeněk PAVLOVSKÝ, Zdeněk KALA and Lumír KUNOVSKÝ. Myofibroblastic tumor of the esophagus - a case report of long-term follow-up and literature review. Klinická onkologie. Praha: Česká lékařská společnost J. E. Purkyně/Ambit Media, a. s., 2021, vol. 34, No 4, p. 313-318. ISSN 0862-495X. Available from: https://dx.doi.org/10.48095/ccko2021313.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Myofibroblastic tumor of the esophagus - a case report of long-term follow-up and literature review
Authors VACULOVÁ, Jitka (203 Czech Republic, belonging to the institution), Jiří DOLINA (203 Czech Republic, belonging to the institution), Petr JABANDŽIEV (203 Czech Republic, belonging to the institution), Martin ŠTĚRBA (203 Czech Republic, belonging to the institution), Jiří TŮMA (203 Czech Republic, belonging to the institution), Robert DOUŠEK (203 Czech Republic, belonging to the institution), Ladislav PLÁNKA (203 Czech Republic, belonging to the institution), Jan ŠENKYŘÍK (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution), Viera BAJČIOVÁ (703 Slovakia, belonging to the institution), Michal EID (203 Czech Republic, belonging to the institution), Zdeněk PAVLOVSKÝ (203 Czech Republic, belonging to the institution), Zdeněk KALA (203 Czech Republic, belonging to the institution) and Lumír KUNOVSKÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Klinická onkologie, Praha, Česká lékařská společnost J. E. Purkyně/Ambit Media, a. s. 2021, 0862-495X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/21:00120183
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.48095/ccko2021313
Keywords in English inflamamtory pseudotumor; esophageal carcinoma; myofibroblastic tumor; plasma cell granuloma; endoscopy; surgery
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 21/12/2021 09:20.
Abstract
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm with intermediate malignant potential. Although most often seen in the lungs, it can occur at multiple anatomical locations, including the gastrointestinal tract. An esophageal lesion is extremely rare, however. IMTs present most commonly in children and young adults. The main therapeutic approach is surgical resection. Case report: We report on the follow-up of a case in a 13-year-old boy with IMT in the esophagus. He underwent surgical resection in 2013 and is free of disease to date. Conclusion: Surgical resection is the most preferred therapy. If the resection is complete, the risk of recurrence is low. Nevertheless, every patient should be carefully followed up after the resection.
Links
NU20-03-00126, research and development projectName: Hostitelský mikrobiom ve vztahu k rozvoji Barrettova jícnu a adenokarcinomu jícnu
Investor: Ministry of Health of the CR, Host microbiome in relation to Barrett ́s esophagus and esophageal adenocarcinoma development, Subprogram 1 - standard
PrintDisplayed: 24/7/2024 18:27